1. Home
  2. TNK vs ADPT Comparison

TNK vs ADPT Comparison

Compare TNK & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

N/A

Current Price

$74.34

Market Cap

2.7B

ML Signal

N/A

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$14.44

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNK
ADPT
Founded
2007
2009
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
TNK
ADPT
Price
$74.34
$14.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$77.00
$17.78
AVG Volume (30 Days)
552.8K
1.5M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
2.79%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$276,976,000.00
Revenue This Year
N/A
$3.98
Revenue Next Year
N/A
$22.72
P/E Ratio
$8.05
N/A
Revenue Growth
N/A
54.77
52 Week Low
$33.35
$6.26
52 Week High
$82.24
$20.76

Technical Indicators

Market Signals
Indicator
TNK
ADPT
Relative Strength Index (RSI) 58.58 34.19
Support Level $42.26 $12.32
Resistance Level $82.24 $17.72
Average True Range (ATR) 2.88 0.71
MACD -0.56 -0.08
Stochastic Oscillator 33.39 7.52

Price Performance

Historical Comparison
TNK
ADPT

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: